USPTO trademark

Isomorphic Labs Limited design mark 7781620

RegisteredUSPTOFigurative markClass 9Class 42

"Design mark 7781620" is a figurative mark owned by Isomorphic Labs Limited, filed at the USPTO on February 17, 2022. It is registered and covers classes 9 and 42.

Official USPTO record
Isomorphic Labs Limited design mark 7781620 trademark as filed
As filed with the USPTO
Status
Registered
Since May 6, 2025
Filed
February 17, 2022
Registered
May 6, 2025
Expires
Not recorded
Application no.
97272458
Registration no.
7781620
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
2 classes
Ownership

Who owns Isomorphic Labs Limited design mark 7781620

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services Isomorphic Labs Limited design mark 7781620 is filed for, grouped by Nice class.

  • Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software applications for designing and developing artificial intelligence, information technology, deep learning technologies, machine learning technologies, and reinforcement learning technologies for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for software development in the fields of software for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development

  • Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the fields of artificial intelligence, machine learning technologies, deep learning technologies, and reinforcement learning technologies, all for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the fields of artificial intelligence, machine learning technologies, deep learning technologies, and reinforcement learning technologies, all for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; development and testing of computing methods, computer software algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research and technological consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology, and scientific research; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Applicant/correspondence changes (non-responsive) entered
  5. Teas change of owner address received
  6. Notice of registration confirmation emailed
  7. Registered-principal register
  8. Official gazette publication confirmation e-mailed
  9. Published for opposition
  10. Notification of notice of publication e-mailed

10 earlier steps on the official record.

FAQ

About Isomorphic Labs Limited design mark 7781620

Who owns the trademark "Design mark 7781620"?

The USPTO trademark "Design mark 7781620" (application 97272458) is owned by Isomorphic Labs Limited.

What is the status of "Design mark 7781620"?

Its status at the USPTO is: registered.

When was "Design mark 7781620" registered?

It was registered on May 6, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Isomorphic Labs Limited design mark 7781620 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2a37-2911-70ed-936b-8cb5860276ef
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a37-2911-70ed-936b-8cb5860276ef",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97272458",
  "filing_date": "2022-02-17",
  "nice_classes": [
    9,
    42
  ],
  "owners": [
    {
      "name": "Isomorphic Labs Limited",
      "entity_id": "ent_019eb7c9-3699-730a-bc89-d456a3a4d4bf"
    }
  ]
}